Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?

被引：4

作者：

Ando, H

Takamura, T

Kobayashi, K

Misu, H

Osawa, K

机构：

[1] Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa 9208641, Japan

[2] Tonami Gen Hosp, Dept Endocrinol, Tonami 9391395, Japan

来源：

ATHEROSCLEROSIS | 2003年 / 166卷 / 02期

关键词：

D O I：

10.1016/S0021-9150(02)00378-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：413 / 414

页数：2

共 9 条

[1] STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS
ADERKA, D
ENGELMANN, H
MAOR, Y
BRAKEBUSCH, C
WALLACH, D
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 323 - 329
[2] Ando H, 2000, J PHARMACOL EXP THER, V294, P1043
[3] Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: No clear relationship with levels of tumor necrosis factor
Blann, AD
McCollum, CN
[J]. INFLAMMATION, 1998, 22 (05) : 483 - 491
[4] Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance
Fernández-Real, JM
Broch, M
Ricart, W
Casamitjana, R
Gutierrez, C
Vendrell, J
Richart, C
[J]. DIABETES, 1998, 47 (11) : 1757 - 1762
[5] Freeman DJ, 2001, CIRCULATION, V103, P357
[6] ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE
HOTAMISLIGIL, GS
SHARGILL, NS
SPIEGELMAN, BM
[J]. SCIENCE, 1993, 259 (5091) : 87 - 91
[7] INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE
HOTAMISLIGIL, GS
ARNER, P
CARO, JF
ATKINSON, RL
SPIEGELMAN, BM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) : 2409 - 2415
[8] Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages
Pahan, K
Sheikh, FG
Namboodiri, AMS
Singh, I
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) : 2671 - 2679
[9] Reduced levels of TNFα in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
Solheim, S
Seljeflot, I
Arnesen, H
Eritsland, J
Eikvar, L
[J]. ATHEROSCLEROSIS, 2001, 157 (02) : 411 - 415

← 1 →